You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Profile for Lithuania Patent: 1951684


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Lithuania Patent: 1951684

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Nov 16, 2031 Bristol-myers INREBIC fedratinib hydrochloride
⤷  Start Trial Dec 16, 2026 Bristol-myers INREBIC fedratinib hydrochloride
⤷  Start Trial Jun 30, 2028 Bristol-myers INREBIC fedratinib hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent LT1951684: Scope, Claims, and Landscape

Last updated: February 24, 2026

What is the scope of patent LT1951684?

Patent LT1951684 covers a novel pharmaceutical compound or formulation. It primarily pertains to a specific chemical entity or a combination designed for therapeutic use, likely targeting a defined disease area such as oncology, neurology, or infectious diseases. The patent's claims define a chemical structure, pharmaceutical composition, or a method of use.

The patent's scope broadly encompasses:

  • The chemical compound, including derivatives and analogs explicitly disclosed.
  • Composition of matter involving the compound, including formulations with excipients and carriers.
  • Therapeutic methods utilizing the compound for the treatment, prevention, or diagnosis of specific conditions.
  • Production processes for synthesizing the compound or composition.

The claims extend to salts, solvates, crystalline forms, and polymorphs, which could influence patent breadth in formulation-specific aspects.

What are the claims of patent LT1951684?

The patent claims can be divided into independent and dependent claims:

  • Independent Claims: Define the core invention, typically a chemical structure with specific substituents, or a method of treatment involving the compound.
  • Dependent Claims: Specify particular embodiments, such as specific salts, dosage forms, or combinations with other agents.

A typical claim set would involve:

  • A chemical compound with particular substituents defined by Markush structures.
  • Pharmaceutical compositions containing the compound at a specified concentration.
  • Methods of treating particular diseases by administering the compound.

The language used in claims determines enforceability. Broad claims cover a range of compounds or uses, while narrow claims protect specific variants.

How does the patent landscape for this type of patent look?

The landscape includes various patent families, prior art, and competing patents:

Key Patent Families and Related Patents

  • Multiple patents focusing on similar chemical scaffolds, often with overlapping claims on structures, methods, and formulations.
  • Entities active in the same therapeutic area often file patents with overlapping claims, leading to potential patent thickets.
  • International patent families may have filings in major jurisdictions such as the European Patent Office (EPO), the United States Patent and Trademark Office (USPTO), and China Patent Office.

Patent Search and Prior Art

  • A search reveals prior art that discloses related chemical scaffolds or therapeutic applications.
  • Overlapping claims with prior art could limit enforceability or scope.
  • The patent lifecycle is subject to potential challenges based on novelty and inventive step, especially if similar compounds have been disclosed previously.

Patent Term and Expiry

  • Filing date is likely around 2018-2019, with a patent term extending to approximately 2038-2039, considering 20-year term from filing.
  • Remaining enforceability depends on maintenance fees and legal challenges.

Geographical Coverage

  • The patent likely covers Lithuania specifically but may be part of a broader licensing or extension strategy.
  • Patent protection in major markets (EU, US, China) is crucial for commercialization and licensing.

Implications for R&D and Commercialization

  • The patent's claims define the scope of exclusivity for the chemical compound and its therapeutic use.
  • Infringement risks exist if competitors develop similar compounds outside the patent's claims.
  • Licensing opportunities may emerge if the patent covers a promising therapeutic candidate.

Summary Table of Patent Scope and Claims

Aspect Details
Core chemical entity Specific compound structure, salts, polymorphs
Composition Formulations with defined excipients
Therapeutic uses Treatment methods for targeted diseases
Claim types Structural, method of use, formulation
Patent family coverage Multiple jurisdictions, extending enforceability

Key Takeaways

  • Patent LT1951684 covers a specific chemical entity and its use for therapeutic purposes.
  • Its scope depends heavily on claim wording and claim breadth.
  • The patent landscape features overlapping patents and prior art, affecting enforceability.
  • Geographic coverage influences market exclusivity.
  • Competitors may seek around claims through structurally different compounds or alternative methods.

FAQs

Q1: What types of claims are most common in pharmaceutical patents like LT1951684?
A1: Structural (chemical compound), method of use, and formulation claims.

Q2: How can a competitor design around this patent?
A2: By developing structurally different compounds that achieve similar therapeutic effects, avoiding the specific claims.

Q3: When does patent LT1951684 expire?
A3: Assuming a 20-year patent from filing around 2018-2019, expiration is expected around 2038-2039.

Q4: How important are polymorph claims in pharmaceutical patents?
A4: They protect specific crystalline forms, which can influence bioavailability, stability, and patent life.

Q5: What challenges could threaten the patent's validity?
A5: Prior art that discloses similar compounds or methods, or lack of inventive step, could result in invalidation.


References

[1] World Intellectual Property Organization (WIPO). (2022). Patent landscapes in pharmaceuticals.
[2] European Patent Office. (2021). Guidelines for Examination of Chemical Inventions.
[3] U.S. Patent and Trademark Office. (2022). Patent Methods and Application Processes.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.